Trade Names: | |
Synonyms: | |
Status: | Approved (2017) |
Entry Type: | Antibody |
Molecule Category: | UNKNOWN |
ATC: | D11AH05 |
UNII: | 420K487FSG |
Action | Mechanism of Action | Reference |
---|---|---|
ANTAGONIST | Interleukin-4 receptor subunit alpha antagonist | PubMed |
Primary Target | |
---|---|
Interleukin-4 receptor subunit α |
Mesh Heading | Maximum Phase | Mesh ID | Reference |
---|---|---|---|
Nasal Polyps | 4 | D009298 | ClinicalTrials |
Dermatitis, Atopic | 4 | D003876 | FDA |
Urticaria | 3 | D014581 | ClinicalTrials |
Eosinophilic Esophagitis | 3 | D057765 | ClinicalTrials |
Pulmonary Disease, Chronic Obstructive | 3 | D029424 | ClinicalTrials |
Aspergillosis, Allergic Bronchopulmonary | 3 | D001229 | ClinicalTrials |
Dermatitis | 3 | D003872 | ClinicalTrials |
Asthma | 3 | D001249 | ClinicalTrials |
Sinusitis | 3 | D012852 | ClinicalTrials |
Neurodermatitis | 3 | D009450 | ClinicalTrials |
Severe Acute Respiratory Syndrome | 2 | D045169 | ClinicalTrials |
Alopecia Areata | 2 | D000506 | ClinicalTrials |
Respiratory Tract Diseases | 2 | D012140 | ClinicalTrials |
Rhinitis, Allergic, Seasonal | 2 | D006255 | ClinicalTrials |
Peanut Hypersensitivity | 2 | D021183 | ClinicalTrials |
Angioedema | 2 | D000799 | ClinicalTrials |
Conjunctivitis, Allergic | 2 | D003233 | ClinicalTrials |
Pemphigoid, Bullous | 2 | D010391 | ClinicalTrials |
Scleroderma, Localized | 2 | D012594 | ClinicalTrials |
Pruritus | 2 | D011537 | ClinicalTrials |
Prostatic Neoplasms, Castration-Resistant | 2 | D064129 | ClinicalTrials |
Netherton Syndrome | 2 | D056770 | ClinicalTrials |
Resources | Reference |
---|---|
CAS NUMBER | 1190264-60-8 |
ChEMBL | CHEMBL2108675 |
FDA SRS | 420K487FSG |
Guide to Pharmacology | 7574 |